Consistent with these observations, increased MRCKα gene copy number was detected in 542 of 852 (64%) breast cancer samples at the Wellcome Trust Sanger Institute Cancer Genome Project (https://www.sanger.ac.uk/research/projects/cancergenome/). Here, CDC42BPA is linked to breast carcinoma.